Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

No open-market purchases or sales by ImmunityBio, Inc. insiders were filed in the last 90 days; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

Q1 2025 vs. Q4 2024

How the institutions holding ImmunityBio, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of IBRX: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders2023211+12
Shares82.7M376.2K79.6M−2.72M (−3.3%)
Value$211.8M$963.2K$239.4M+$28.6M (+13.6%)

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held ImmunityBio, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to IBRX in Q1 2025
InstitutionSharesValue% of portfolio
Nuveen, LLC359,669$1.08M0.00%
HRT Financial LP237,761$715.0K0.00%
Virtus Investment Advisers, Inc.118,100$355.5K0.10%
Dauntless Investment Group, LLC94,141$283.4K1.05%
Good Life Advisors, LLC57,311$172.5K0.01%
Balyasny Asset Management LLC56,165$169.1K0.00%
Mariner, LLC46,596$140.3K0.00%
SIH Partners, LLLP46,017$138.5K0.01%
Gotham Asset Management, LLC45,005$135.5K0.00%
Bristlecone Advisors, LLC36,000$108.4K0.01%
Caption Management, LLC25,000$75.3K0.00%
Tudor Investment Corp Et Al24,253$73.0K0.00%
Sequoia Financial Advisors, LLC20,067$60.4K0.00%
Cambridge Investment Research Advisors, Inc.17,950$54.0K0.00%
Meeder Advisory Services, Inc.15,984$48.1K0.00%
Axq Capital, LP14,674$44.2K0.02%
CenterStar Asset Management, LLC14,400$43.4K0.06%
Eqis Capital Management, Inc.13,650$41.1K0.00%
Grant/GrossMendelsohn, LLC15,105$39.7K0.02%
Cetera Investment Advisers11,820$35.6K0.00%
SEI Investments Co11,809$35.5K0.00%
Humankind Investments LLC11,184$33.7K0.01%
Xponance, Inc.11,021$33.2K0.00%
Federation des caisses Desjardins du Quebec11,000$33.1K0.00%
Captrust Financial Advisors10,741$32.3K0.00%
Thrive Wealth Management, LLC10,077$30.3K0.01%
Atomi Financial Group, Inc.10,024$30.2K0.00%
Slow Capital, Inc.10,000$30.1K0.00%
Acadian Asset Management LLC7,963$23.0K0.00%
CIBC Private Wealth Group, LLC3,500$8.47K0.00%
US Bancorp2,791$8.40K0.00%
Parallel Advisors, LLC2,000$6.02K0.00%
Wiser Advisor Group LLC2,000$6.02K0.01%
Boston Private Wealth LLC1,780$5.36K0.00%
BFSG, LLC1,300$3.91K0.00%
Sound Income Strategies, LLC1,100$3.31K0.00%
Hexagon Capital Partners LLC1,000$3.01K0.00%
Skopos Labs, Inc.680$2.05K0.00%
Signaturefd, LLC282$8490.00%
Parkside Financial Bank & Trust175$5270.00%
Allworth Financial LP105$2830.00%
Coldstream Capital Management Inc84$2530.00%
True Wealth Design, LLC8$250.00%
HFM Investment Advisors, LLC6$190.00%
Bay Harbor Wealth Management, LLC6$180.00%

Sold out (33)

Institutions that held ImmunityBio, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (3)

Institutions that held ImmunityBio, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IBRX in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC355,302$909.6K
Carlson Capital Management20,000$51.2K
Global Retirement Partners, LLC930$2.38K